Abstract:Humans are chronically exposed to furan, a potent liver toxicant and carcinogen that occurs in a variety of heat-processed foods. Assessment of human exposure based on the furan content in foods is, however, subject to some uncertainty due to the high volatility of furan. Biomarker monitoring is thus considered an alternative or complementary approach to furan exposure assessment. Previous work suggested that urinary furan metabolites derived from the reaction of cis -2-butene-1,4-dial (BDA), the reactive intermediate of furan, with glutathione (GSH) or amino acids may serve as potential biomarkers of furan exposure. However, some metabolites were also reported to occur in urine of untreated animals, indicating either background contamination via animal feed or endogenous sources, which may limit their suitability as biomarkers of exposure. The overall aim of the present study was to accurately establish the correlation between external dose and concentration of furan metabolites in urine over time and to discriminate against endogenous formation and furan intake via feed. To this end, the furan metabolites GSH-BDA ( N -[4-carboxy-4-(3-mercapto-1 H -pyrrol-1-yl)-1-oxobutyl]-L-cysteinylglycine), NAcLys-BDA ( R -2-(acetylamino)-6-(2,5-dihydro-2-oxo-1 H -pyrrol-1-yl)-1-hexanoic acid), NAcCys-BDA-NAcLys ( N -acetyl-S-[1-[5-(acetylamino)-5-carboxypentyl]-1 H -pyrrol-3-yl]-L-cysteine) and NAcCys-BDA-NAcLys sulfoxide ( N -acetyl-S-[1-[5-(acetylamino)-5-carboxypentyl]-1 H -pyrrol-3-yl]-L-cysteine sulfoxide) were simultaneously analyzed by stable isotope dilution ESI–LC–MS/MS as unlabeled and [ 13 C 4 ]-furan dependent metabolites following oral administration of a single oral dose of isotopically labelled [ 13 C 4 ]-furan (0.1, 1, 10, 100 and 1000 μg/kg bw) to male and female F344/DuCrl rats. Although a linear correlation between urinary excretion of [ 13 C 4 ]-furan-dependent metabolites was observed, analysis of unlabeled NAcLys-BDA, NAcCys-BDA-NAcLys and NAcCys-BDA-NAcLys sulfoxide revealed substantial, fairly constant urinary background levels throughout the course of the study. Analysis of furan in animal feed excluded feed as a source for these background levels. GSH-BDA was identified as the only furan metabolite without background occurrence, suggesting that it may present a specific biomarker to monitor external furan exposure. Studies in humans are now needed to establish if analysis of urinary GSH-BDA may provide reliable exposure estimates.

Feature MS Fragments-Based Method for Identification of Toxic Furanoids in Biological Samples.

Development of a Sensitive and Quantitative Method for the Identification of Two Major Furan Fatty Acids in Human Plasma

Global Detection And Identification Of Components From Crude And Processed Traditional Chinese Medicine By Liquid Chromatography Connected With Hybrid Ion Trap And Time-Of-Flight-Mass Spectrometry

Rewiring cis-2-butene-1,4-dial mediated urinary metabolomics fingerprints of short-term exposure to furan

Validation of putative biomarkers of furan exposure through quantitative analysis of furan metabolites in urine of F344 rats exposed to stable isotope labeled furan

A Reliable Isotope Dilution Method for Simultaneous Determination of Fumonisins B1, B2 and B3 in Traditional Chinese Medicines by Ultra-High-performance Liquid Chromatography-Tandem Mass Spectrometry.

A Metabolic Activation-Based Chemoproteomic Platform to Profile Adducted Proteins Derived from Furan-Containing Compounds.

Characterization and identification of steroidal alkaloids in Fritillaria species using liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry

Rapid screening and identification of metabolites of murpanicin in rats by UHPLC/Q-TOF-MS/MS combined with diagnostic fragment ions (DFIs) and multiple mass defect filter

Identification of 3′,4′-Dimethoxy Flavonol-3-β-d-Glucopyranoside Metabolites in Rats by Liquid Chromatography-Electrospray Ionization Ion Trap Mass Spectrometry

Identification of Flurochloridone Metabolites in Rat Urine Using Liquid Chromatography/high Resolution Mass Spectrometry.

Analysis of Furo[3,2-C]Tetrahydroquinoline and Pyrano[3,2-C]Tetrahydroquinoline Derivatives As Antitumor Agents and Their Metabolites by Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry

Determination of Furan and Its Derivatives in Preserved Dried Fruits and Roasted Nuts Marketed in China Using an Optimized HS-SPME GC/MS Method

Application of Mass Spectrometry Fragmentation Patterns for Rapid Screening and Structure Identification of Fentanyl Analogues in Suspicious Powder

Characterization of in Vivo and in Vitro Metabolites of Furanodiene in Rats by High Performance Liquid Chromatography-Electrospray Ionization Mass Spectrometry and Nuclear Magnetic Resonance Spectra

Metabolic Activation and Hepatotoxicity of Furan-containing Compounds

Identification and structural characterization of febuxostat metabolites in rat serum and urine samples using UHPLC-QTOF/MS.

In-depth characterization of cycloartane triterpenoids and discovery of species-specific markers from three Cimicifuga species guided by a strategy that integrates in-source fragment elimination, diagnostic ion recognition, and feature-based molecular networking

Mechanistic and predictive studies on the oxidation of furans by cytochrome P450: A DFT study

Systematic establishment of the relationship between skin absorption and toxicity of furanoids via in silico, in vitro, and in vivo assessments

Detection of gyromitrin-induced mushroom poisoning by an isotope-coded derivatization strategy combined with UPLC-MS/MS and its application